Suchergebnisse - "Tarantini, Luigi"

PubPharm (7)

1

Cardiovascular Risk After Adjuvant Trastuzumab in Early Breast Cancer : An Italian Population-Based Cohort Study

enthalten in: The oncologist | 2020

von Franchi, M. | Trama, A. | Merlo, I. | +11

2

Cardiovascular Risk Factors and Timing of Anthracyclines and Trastuzumab Cardiac Toxicity

enthalten in: Anticancer research | 2019

von Canale, M. | Camerini, A. | Huqi, A. | +11

3

Role of hypertension on new onset congestive heart failure in patients receiving trastuzumab therapy for breast cancer

enthalten in: Journal of cardiovascular medicine (Hagerstown, Md.) | 2014

von Russo, G. | Cioffi, G. | Gori, S. | +43

4

Role of renal function on the development of cardiotoxicity associated with trastuzumab-based adjuvant chemotherapy for early breast cancer

enthalten in: Internal and emergency medicine | 2012

von Russo, G. | Cioffi, G. | Di Lenarda, A. | +7

CommentIn: Intern Emerg Med. 2012 Oct;7(5):399-401. - PMID 22941411

5

Heart failure in women treated with adjuvant trastuzumab for breast cancer

enthalten in: Giornale italiano di cardiologia (2006) | 2012

von Tarantini, L. | Feola, M. | Albini, A. | +4

6

Trastuzumab adjuvant chemotherapy and cardiotoxicity in real-world women with breast cancer

enthalten in: Journal of cardiac failure | 2012

von Tarantini, L. | Cioffi, G. | Gori, S. | +42

7

Administration of angiotensin-converting enzyme inhibitors and β-blockers during adjuvant trastuzumab chemotherapy for nonmetastatic breast cancer : marker of risk or cardioprotection in the real world?

enthalten in: The oncologist | 2012

von Oliva, S. | Cioffi, G. | Frattini, S. | +11

1
[1]